Kresken M - Search Results

1

Antibiotic resistance and molecular characterization of non-invasive clinical Haemophilus influenzae isolates in Germany 2019 and 2020.

Frank T, Wohlfarth E, Claus H, Krone M, Lâm TT, Kresken M; Study Group ‘Antimicrobial Resistance’ of the Paul Ehrlich Society for Infection Therapy. Frank T, et al. Among authors: kresken m. JAC Antimicrob Resist. 2024 Dec 10;6(6):dlae197. doi: 10.1093/jacamr/dlae197. eCollection 2024 Dec. JAC Antimicrob Resist. 2024. PMID: 39659639 Free PMC article.

2

Presence of hypervirulence-associated determinants in Klebsiella pneumoniae from hospitalised patients in Germany.

Wahl A, Fischer MA, Klaper K, Müller A, Borgmann S, Friesen J, Hunfeld KP, Ilmberger A, Kolbe-Busch S, Kresken M, Lippmann N, Lübbert C, Marschner M, Neumann B, Pfennigwerth N, Probst-Kepper M, Rödel J, Schulze MH, Zautner AE, Werner G, Pfeifer Y. Wahl A, et al. Among authors: kresken m. Int J Med Microbiol. 2024 Mar;314:151601. doi: 10.1016/j.ijmm.2024.151601. Epub 2024 Feb 8. Int J Med Microbiol. 2024. PMID: 38359735 Free article.

3

Whole genome analyses of CMY-2-producing Escherichia coli isolates from humans, animals and food in Germany.

Pietsch M, Irrgang A, Roschanski N, Brenner Michael G, Hamprecht A, Rieber H, Käsbohrer A, Schwarz S, Rösler U, Kreienbrock L, Pfeifer Y, Fuchs S, Werner G; RESET Study Group. Pietsch M, et al. BMC Genomics. 2018 Aug 9;19(1):601. doi: 10.1186/s12864-018-4976-3. BMC Genomics. 2018. PMID: 30092762 Free PMC article.

4

Antimicrobial Susceptibility of Bacterial Pathogens from Patients with Ocular Surface Infections in Germany, 2020-2021: A Comparison with the Data from Three Previous National Studies.

Wohlfarth E, Kresken M, Deuchert F. Wohlfarth E, et al. Among authors: kresken m. Antibiotics (Basel). 2024 May 21;13(6):471. doi: 10.3390/antibiotics13060471. Antibiotics (Basel). 2024. PMID: 38927138 Free PMC article.

5

[Therapy of cystitis with nitroxoline-NitroxWin : Prospective, multicenter, non-interventional study and microbiological resistance surveillance].

Wagenlehner F, Kresken M, Wohlfarth E, Bahrs C, Grabein B, Strohmaier WL, Naber KG. Wagenlehner F, et al. Among authors: kresken m. Urologie. 2023 Nov;62(11):1186-1192. doi: 10.1007/s00120-023-02167-5. Epub 2023 Aug 31. Urologie. 2023. PMID: 37650911 Free PMC article. German.

6

Letter to the editor: Antimicrobial resistance data and treatment guidelines - challenges in the context of urine samples and mecillinam testing.

Abu Sin M, Wohlfarth E, Klingeberg A, Eckmanns T, Kresken M, Kramme E, Werner G. Abu Sin M, et al. Among authors: kresken m. Euro Surveill. 2023 Aug;28(32):2300418. doi: 10.2807/1560-7917.ES.2023.28.32.2300418. Euro Surveill. 2023. PMID: 37561051 Free PMC article. No abstract available.

7

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates.

Seifert H, Müller C, Stefanik D, Higgins PG, Wohlfarth E, Kresken M. Seifert H, et al. Among authors: kresken m. Antibiotics (Basel). 2023 Jul 11;12(7):1172. doi: 10.3390/antibiotics12071172. Antibiotics (Basel). 2023. PMID: 37508268 Free PMC article.

8

Escherichia coli resistance, treatment patterns and clinical outcomes among females with uUTI in Germany: a retrospective physician-based chart review study.

Naber KG, Wagenlehner F, Kresken M, Cheng WY, Catillon M, Duh MS, Yu L, Khanal A, Mulgirigama A, Joshi AV, Ju S, Mitrani-Gold FS. Naber KG, et al. Among authors: kresken m. Sci Rep. 2023 Jul 26;13(1):12077. doi: 10.1038/s41598-023-38919-8. Sci Rep. 2023. PMID: 37495602 Free PMC article.

9

In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17.

Wohlfarth E, Kresken M, Deuchert F, Gatermann SG, Pfeifer Y, Pfennigwerth N, Seifert H, Higgins PG, Werner G, Study Group 'Antimicrobial Resistance' Of The Paul Ehrlich Society For Infection Therapy. Wohlfarth E, et al. Among authors: kresken m. Antibiotics (Basel). 2023 May 6;12(5):864. doi: 10.3390/antibiotics12050864. Antibiotics (Basel). 2023. PMID: 37237767 Free PMC article.

10

Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of Enterobacteriaceae and Enterococci.

Blanchard LS, Armstrong TP, Kresken M, Emery CL, Ying YX, Sauvonnet V, Zambardi G. Blanchard LS, et al. Among authors: kresken m. J Clin Microbiol. 2023 Mar 23;61(3):e0165022. doi: 10.1128/jcm.01650-22. Epub 2023 Mar 6. J Clin Microbiol. 2023. PMID: 36877080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters